Maciej Garbowski

1.5k citations

35 papers · 1.1k indexed · 1 hit paper · h-index 15

Co-authors: John B. Porter Dudley J. Pennell Robert C. Hider J.M. Alústiza Benjamin Henninger Y. Gandon John‐Paul Carpenter Taigang He
Topics: Hemoglobinopathies and Related Disorders (27 papers)Iron Metabolism and Disorders (24 papers)Erythropoietin and Anemia Treatment (7 papers)
Cited by: Hematology Genetics Nutrition and Dietetics
Journals: Circulation Blood European Heart Journal
Partner nations: United Kingdom United States Switzerland

In The Last Decade

Maciej Garbowski

35 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction

2019 226 citations Maciej Garbowski et al. profile →

Peers

Countries citing papers authored by Maciej Garbowski

Since Specialization

Citations

This map shows the geographic impact of Maciej Garbowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maciej Garbowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maciej Garbowski more than expected).

Fields of papers citing papers by Maciej Garbowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maciej Garbowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maciej Garbowski. The network helps show where Maciej Garbowski may publish in the future.

Co-authorship network of co-authors of Maciej Garbowski

This figure shows the co-authorship network connecting the top 25 collaborators of Maciej Garbowski. A scholar is included among the top collaborators of Maciej Garbowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maciej Garbowski. Maciej Garbowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Luspatercept stimulates erythropoiesis, increases iron utilization, and redistributes body iron in transfusion‐dependent thalassemia 2023 ·American Journal of Hematology ·Maciej Garbowski,(unknown),Alberto Risueño,Jeevan K. Shetty,Martin Schwickart,Olivier Hermine,John B. Porter,Anjan Thakurta,(unknown)	13
2	Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development 2021 ·Expert Review of Hematology ·John B. Porter,Alì Taher,Vip Viprakasit,Antonis Kattamis,Thomas D. Coates,Maciej Garbowski,Franz Dürrenberger,Vania Manolova,Frank Richard,Maria Domenica Cappellini	15
3	Luspatercept Redistributes Body Iron to the Liver in Transfusion-Dependent-Thalassemia (TDT) during Erythropoietic Response 2021 ·Blood ·Maciej Garbowski,(unknown),Alberto Risueño,Rajasekhar N.V.S. Suragani,Jeevan K. Shetty,(unknown),Anjan Thakurta,Martin Schwickart,John B. Porter	2
4	Intravenous iron preparations transiently generate non-transferrin-bound iron from two proposed pathways 2020 ·Haematologica ·Maciej Garbowski,Sukhvinder S. Bansal,John B. Porter,Claudio Mori,Susanna Burckhardt,Robert C. Hider	30
5	Effect of Luspatercept on Biomarkers of Erythropoiesis in Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the Medalist Trial 2020 ·Blood ·Uwe Platzbecker,(unknown),(unknown),Alberto Risueño,Esther T. Chan,George Zhang,Diana Dunshee,Melih Acar,Jeevan K. Shetty,(unknown),Kyle J. MacBeth,Valeria Santini,Maciej Garbowski,Pierre Fenaux,Martin Schwickart	2
6	Extracts of ThaiPerilla frutescensnutlets attenuate tumour necrosis factor-α-activated generation of microparticles, ICAM-1 and IL-6 in human endothelial cells 2020 ·Bioscience Reports ·(unknown),Niramon Utama‐ang,Chairat Uthaipibull,John B. Porter,Maciej Garbowski,Somdet Srichairatanakool	12
7	Is There a Role for Titre Monitoring in Kell Alloimmunized Pregnancies? 2019 ·Blood ·(unknown),Maciej Garbowski,Gareth Seaward,Rory Windrim,Johannes Keunen,Edmond Kelly,(unknown),Nadine Shehata,Greg Ryan	4
8	Practical guide to quantification of hepatic iron with MRI 2019 ·European Radiology ·Benjamin Henninger,J.M. Alústiza,Maciej Garbowski,Y. Gandon	92
9	Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study 2018 ·Haematologica ·Maria Domenica Cappellini,John B. Porter,Raffaella Origa,Gian Luca Forni,Ersi Voskaridou,Frédéric Galactéros,Alì Taher,J Arlet,Jean‐Antoine Ribeil,Maciej Garbowski,Giovanna Graziadei,Chantal Brouzes,Michaëla Semeraro,Abderrahmane Laadem,Dimana Miteva,Jun Zou,Victoria Sung,Tatiana Zinger,Kenneth M. Attie,Olivier Hermine	68
10	Interaction of Transfusion and Iron Chelation in Thalassemias 2018 ·Hematology/Oncology Clinics of North America ·John B. Porter,Maciej Garbowski	13
11	Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin 2017 ·Haematologica ·Maciej Garbowski,Patricia Evans,Evangelia Vlachodimitropoulou,Robert C. Hider,John B. Porter	18
12	Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator 2017 ·Blood ·Evangelia Vlachodimitropoulou,Yulin Chen,Maciej Garbowski,Pimpisid Koonyosying,Bethan Psaila,Martha Sola‐Visner,Nichola Cooper,Robert C. Hider,John B. Porter	94
13	Clinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assay 2016 ·Translational research ·Maciej Garbowski,Yongmin Ma,Suthat Fucharoen,Somdet Srichairatanakool,Robert C. Hider,John B. Porter	17
14	Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan 2014 ·Journal of Cardiovascular Magnetic Resonance ·Maciej Garbowski,John‐Paul Carpenter,Gillian Smith,Sy Ha,Mohammed H Alam,Taigang He,Dudley J. Pennell,John B. Porter	151
15	The Pathophysiology of Transfusional Iron Overload 2014 ·Hematology/Oncology Clinics of North America ·John B. Porter,Maciej Garbowski	79
16	Mechanisms of plasma non‐transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients 2014 ·British Journal of Haematology ·John B. Porter,Patrick B. Walter,Lynne Neumayr,Patricia Evans,Sukhvinder S. Bansal,Maciej Garbowski,(unknown),Paul Harmatz,John C. Wood,Jeffery L. Miller,Colleen Byrnes,Günter Weiß,Markus Seifert,Regine Grosse,(unknown),A Schmidt,Roland A. Fischer,Peter Nielsen,Charlotte M. Niemeyer,Elliott Vichinsky	52
17	Consequences and management of iron overload in sickle cell disease 2013 ·Hematology ·John B. Porter,Maciej Garbowski	129
18	A Phase 2a, Open-Label, Dose-Finding Study To Determine The Safety and Tolerability Of Sotatercept (ACE-011) In Adults With Beta (β)-Thalassemia: Interim Results 2013 ·Blood ·Maria Domenica Cappellini,John B. Porter,Raffaella Origa,Gian Luca Forni,(unknown),Frédéric Galactéros,Dimana Miteva,Victoria Sung,Rajesh Chopra,Jean‐Benoît Arlet,Jean‐Antoine Ribeil,K. Klesczewski,Kenneth M. Attie,Maciej Garbowski,Olivier Hermine	14
19	Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload 2010 ·Journal of Cardiovascular Magnetic Resonance ·John‐Paul Carpenter,Francisco Alpendurada,(unknown),Alicia M. Maceira,Maciej Garbowski,Paul Kirk,John M. Walker,John B. Porter,Farrukh Shah,Winston Banya,Taigang He,Gillian Smith,Dudley J. Pennell	18
20	Vitamin C Status in Transfusionally Iron-Overloaded Patients On Long-Term Deferasirox and Its Relationship to Myocardial Iron Removal. 2009 ·Blood ·Maciej Garbowski,Margarete A. Fabre,Patricia Evans,John B. Porter	2

About Maciej Garbowski

Maciej Garbowski is a scholar working on Hematology, Genetics and Nutrition and Dietetics, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (27 papers), Iron Metabolism and Disorders (24 papers) and Erythropoietin and Anemia Treatment (7 papers). The work is most often cited by research in Hematology (756 citations), Genetics (683 citations) and Nutrition and Dietetics (152 citations). Maciej Garbowski has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include John B. Porter, Dudley J. Pennell, Robert C. Hider, J.M. Alústiza, Benjamin Henninger, Y. Gandon, John‐Paul Carpenter, Taigang He, Gillian Smith and Francesca Vinchi. Their work appears in journals such as Circulation, Blood and European Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact